Furthermore, we demonstrate that the hypermethylation of ND6 is attributed to increased DNMT1 mitochondrial localization, which can be promoted by elevated circulating free fatty acid via AMPK activation, suggesting that AMPK/DNMT1 axis may be a potential therapeutic target for the prevention and treatment of IR and T2DM. This evidence concerns the gene DNMT1 and type 2 diabetes mellitus.